Car maker Toyota has announced that it will freely share almost 6,000 patents it owns covering hydrogen fuel cell technology.
It said it took the step in a bid to drive development of cars that use the alternative fuel source.
The announcement was made soon after it showed off its Mirai hydrogen-driven car in Las Vegas.
Toyota is one of a record number of car makers attending CES to unveil new models or connected-car strategies.
Power plan
The patents will be made available free of charge to anyone wanting to use them. The patent portfolio covers fuel cell stacks, high-pressure hydrogen tanks, software control systems and the industrial processes involved in generating and supplying the gas.
“When good ideas are shared, great things can happen,” said Bob Carter, senior vice president of automotive operations at Toyota in a statement.
He added that the first generation of hydrogen fuel cell vehicles, which are expected to be launched over the next five years, would require “unconventional collaboration” among car makers, governments, power firms and researchers.
Read more: CES 2015: Toyota opens up hydrogen patents
The Latest on: Patent sharing
[google_news title=”” keyword=”Patent sharing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Patent sharing
- FTC cracks down on drug patentson May 1, 2024 at 11:07 am
The Federal Trade Commission sent letters to 10 drugmakers April 30 warning them that hundreds of patent listings for 20 drugs are invalid. The agency said "junk" listings keep drug prices high by ...
- Harmony Biosciences Holdings Sell Rating: Concerns Over Product Differentiation, Patent Litigation, and R&D Pipelineon May 1, 2024 at 3:47 am
In a report released yesterday, Jason Gerberry from Bank of America Securities reiterated a Sell rating on Harmony Biosciences Holdings (HRMY ...
- The Simon Law Firm on patent trademark copyright litigationon April 30, 2024 at 2:24 pm
The Intellectual Property Group at The Simon Law Firm assists hourly firms in representing clients in IP litigation matters on a contingency fee basis.
- FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s Howon April 30, 2024 at 10:56 am
The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, GlaxoSmithKline and Teva—disputing more than 300 “junk” patent listings across 20 different brand name ...
- Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patentson April 30, 2024 at 6:54 am
Patent estate covering atrioventricular interval modulation (“AVIM”) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that ...
- Toyota patents tonneau cover with integrated loading ramp systemon April 29, 2024 at 8:44 am
Published by the United States Patent and Trademark Office (USPTO) April 16, 2024, and originally filed by Toyota in 2022, the application details loading ramps that could be stowed on the underside ...
- Unseal Our Shops, Kano Patent Medicine Dealers Beg Govton April 28, 2024 at 12:10 am
Since the Federal High Court judgment endorsing the decision to relocate patent medicine dealers from an open drug market in Sabon Gari to the coordinated Wholesale Centre at Dangwauro village, shops ...
- FMC Corporation: Cyclical Downturn And Patent Expiry Posing A Challengeon April 26, 2024 at 2:30 am
FMC, a global crop protection company, faces challenges with patent expiration and new product initiatives, impacting its growth and profitability. See more here.
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- The patent absurdity of pharmaceutical priceson April 22, 2024 at 11:58 am
Few things are as frustrating as medical care in the United States. Too often when patients complain about minor ailments to their family doctor, they are passed off to specialists who conduct a ...
via Bing News
